# K103799: Inqu Paste Mix Plus

- Pathway: 510(k) (Traditional)
- Applicant: Isto Technologies, Inc.
- Decided: Aug 29, 2011 after 244 days
- Product code: MQV (Filler, Bone Void, Calcium Compound)
- Device class: 2
- Regulation: 21 CFR 888.3045
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 9 generations back to K960978 (1996). 42 ancestors in all.
9 later devices descend from it; 1 cites it directly.
0 of 52 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K063359: INQU, Isto Technologies, Inc. (2007) Summary page 1.
- K071428: INQU, Isto Technologies, Inc. (2007) Summary page 1.
- K093447: Carrigen, Etex Corp. (2010) Summary page 1.

## Most influential descendants
- K130392: Kinex Bioactive (2013), 8 descendants of its own
- K173008: SCS 17-01 (2017), 4 descendants of its own
- K190956: SCS 17-01 (2020), 3 descendants of its own
- K212083: Tactoset Injectable Bone Substitute (2021), 2 descendants of its own
- K223915: Tactoset (2023), 1 descendant of its own

## Indications for use
lnQu® is a resorbable bone void filler intended to fill bony gaps or voids that are not intrinsic to the stability of the bony structure. lnQu® is intended for use as a bone graft substitute in the skeletal system (extremities and pelvis). lnQu® is indicated for use as a bone graft extender in the spine when combined with bone autograft. These defects may be surgically created osseous defects, or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced with bone during the healing process.

Source page: https://510kreport.com/device/K103799
Methodology: https://510kreport.com/methodology